Resource Center

More information?
More information?
25 RESULTS FOUND
Clinical Laboratory Coalition Letter on Office of Inspector General Study on Lab Test Payment Rates 
July 11, 2013
Letter
AdvaMedDx Statement for 2013 Clinical Laboratory Public Meeting
July 10, 2013
Comments
AdvaMedDx Support Letter for HR 2085
May 30, 2013
Letter
Clinical Laboratory Coalition Letter on Cuts to Clinical Lab Fee Schedule in President's Budget
April 16, 2013
Letter
Comments to FDA on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products 
March 18, 2013
Comments
Comments to FDA on Highly Multiplex Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices
February 7, 2013
Comments
Letter to CMS on Payment for Molecular Diagnostic Services
February 5, 2013
Letter
Comments to FDA on CLIA Waiver Applications
November 12, 2012
Comments
Letter to CMS Regarding Clinical Laboratory Fee Schedule Preliminary Payment Determinations and Multianalyte Assays with Algorithmic Analysis
September 28, 2012
Letter
Letter of Support for HR 3497, the Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act, and HR 6446, the Improving Diagnostic Innovations Act
September 24, 2012
Letter
AdvaMed Comments to CMS Regarding Payment for Molecular Pathology Services Under the Physician Fee Schedule
September 4, 2012
Comments
Comments to FDA on Nucleic-Acid Based In Vitro Diagnostic Devices for the Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens 
June 18, 2012
Comments
AdvaMedDx Diagnostic Evidence: Relevant Terms and Definitions
June 1, 2012
Administrative
AdvaMedDx Diagnostic Evidence: Relevant Terms and Definitions (PDF)
June 1, 2012
Administrative
AdvaMedDx Diagnostic Evidence: Relevant Terms and Definitions 
June 1, 2012
Administrative
Letter to the National Institutes of Health Regarding the Genetic Testing Registry 
April 11, 2012
Letter
Clinical Laboratory Coalition Letter to Chairman Baucus
February 15, 2012
Letter
MODDERN Cures Act Support Letter
February 14, 2012
Letter
AdvaMedDx Letter to Palmetto Regarding Molecular Diagnostics Program
December 5, 2011
Letter
AdvaMedDx Summary of the Diagnostic Title of the MODDERN Cures Bill
November 1, 2011
Summary
Response Letter to CLMJE Editors
October 31, 2011
Letter
Draft Guidance for Industry and FDA Staff on In Vitro Companion Diagnostic Devices; Availability
October 12, 2011
Guidance
AdvaMedDx Statement on New Genetic Testing Codes
July 11, 2011
Comments
Statement for Public Meeting on Ultra High Throughput Sequencing for Clinical Diagnostic Applications
June 23, 2011
Comments
Policy Primer on Diagnostics
June 1, 2011
Primer

Pages